Get started
Author

Luiza Novaes Borges

Observed name: Luiza Borges
ORCID: 0000-0001-8634-221X
Observed ORCID: 0000-0001-8634-221X
OpenAlex ID: A5076876633
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report
2024 · Claire Mackie, Sumit Arora, et al. · Molecular Pharmaceutics · 75
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report
2024 · Xavier Pepin, Sumit Arora, et al. · Molecular Pharmaceutics · 41
PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report
2024 · Tycho Heimbach, Flora Musuamba Tshinanu, et al. · Molecular Pharmaceutics · 38
PDF
Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report
2024 · Christer Tannergren, Sumit Arora, et al. · Molecular Pharmaceutics · 33
PDF
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory Submissions
2025 · Sumit Arora, Xavier Pepin, et al. · Molecular Pharmaceutics · 15
PDF
Model-Informed drug development of gastroretentive release systems for sildenafil citrate
2022 · Fabio Pinheiro de Souza, Estevan Sonego Zimmermann, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 13
Integration of artificial neural network and physiologically based biopharmaceutic models in the development of sustained‐release formulations
2023 · Frederico Severino Martins, Luiza Borges, et al. · Biopharmaceutics & Drug Disposition · 7
Experiences and initiatives on pharmacokinetic modeling and simulation data analysis: Perspectives from the Brazilian Health Regulatory Agency (ANVISA)
2024 · Luiza Novaes Borges, Eduardo Agostinho Freitas Fernandes, et al. · Regulatory Toxicology and Pharmacology · 1
Works count: 8
Citation count: 223
H-index: 7
I10-index: 6
Year
Topic
Type